Vous avez cherché: suicidality (Anglais - Maltais)

suicidality
suwiċidalità

suicidality analysis
analiżi ta ’ suwiċidalita ’

therefore patients should be monitored for signs of suicidality during treatment with lamictal.
għalhekk il- pazjenti għandhom ikunu osservati għal sinjali ta 'suwiċidalita' waqt kura b' lamictal.

in addition, the suicidality should be monitored, as depression and mood liability are part of the reported aes for actiq.
barra minn hekk, għandha tiġi mmonitorjata l- possibilità ta 'suwiċidju, billi d - depressjoni u t- tibdil fil- burdata huma parti mill- episodji avversi rrappurtati għal actiq.

results of an epidemiological study found that there was no increased risk of suicidality with aripiprazole compared to other antipsychotics among patients with bipolar disorder.
riżultati ta ’ studju epidemijoloġiku sab illi ma kien hemm ebda żieda fir- riskju ta ’ suwiċidju b’ aripiprazole meta mqabbel ma ’ antipsikotiċi oħrajn fost pazjenti b’ disturbi bipolari.

results of an epidemiological study suggested that there was no increased risk of suicidality with aripiprazole compared to other antipsychotics among adult patients with schizophrenia or bipolar disorder.
riżultati ta’ studju epidemijoloġiku ssuġġerew illi ma kien hemm ebda żieda fir-riskju ta’ suwiċidju b’aripiprazole meta mqabbel ma’ antipsikotiċi oħrajn fost pazjenti adulti bi skizofrenija jew b’disturbi bipolari.

suicidal ideation and behaviours (suicidality) have been reported in patients treated with aeds in several indications, including epilepsy and bipolar disorder.
ideat u aġir ta ’ suwiċidju (suwiċidalita ’) ġew irrapurtati f’ pazjenti ittrattati b' aed f' ħafna indikazzjonijiet, fosthom l- epilessija u d- disturb bi- polari.

in patients with bipolar disorder, worsening of depressive symptoms and/ or the emergence of suicidality may occur whether or not they are taking medications for bipolar disorder, including lamictal.
f’ pazjenti b’ distubi bi- polari, jistgħu imorru għall- agħar sintomi ta 'dipressjoni u/ jew toħroġ is- suwiċidalita' kemm jekk ikunu qed jieħdu l- mediċini għal disturb bi- polari, inkluż lamictal, u kemm jekk le.

therefore patients receiving lamictal for bipolar disorder should be closely monitored for clinical worsening (including development of new symptoms) and suicidality, especially at the beginning of a course of treatment, or at the time of dose changes.
għalhekk pazjenti li qegħdin jirċievu lamictal għal disturbi bi- polari għandhom ikunu osservati mill- qrib għal sitwazzjoni klinika li marret għall- agħar (inkluż iżvilupp ta ’ sintomi ġodda) u suwiċidalita ’, speċjalment fil - bidu ta ’ kors ta ’ kura, jew fiż- żmien meta jkunu qed jinbidlu d- dożi.